Effects of high-intensity high-frequency transcutaneous electric nerve stimulation in primary dysmenorrhea – a randomised cross-over pilot study

2019 ◽  
Vol 22 (5) ◽  
pp. 248-252
Author(s):  
Monika Fagevik Olsén ◽  
Sanna Björndahl ◽  
Anna Ståhl ◽  
Sofie Börjesson ◽  
Anja Sundemo ◽  
...  
2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Chun-Ming Hsieh ◽  
Wan-Chen Lin ◽  
Hsien-Yu Peng ◽  
Huang-Chung Chen ◽  
Yu-Cheng Ho ◽  
...  

AbstractBy enhancing vagal activity, auricle transcutaneous electric nerve stimulation (TENS) is developed as a non-invasive therapy for heart failure. Nevertheless, though shoulder TENS used for treating adhesive capsulitis could affect vagal tone, its potential impact on heart functions remains unclear. In this study, electrocardiogram (ECG) and heart rate (HR) of subjects in response to sham, right-sided, or left-sided shoulder TENS (TENS-S, TENS-R, and TENS-L, respectively; 5 min) were recorded and analyzed. During the stimulation period, TENS-R constantly and TENS-L transiently decreased the HR of subjects; both TENS-R and TENS-L increased powers of the low- and high-frequency spectra. While TENS-R exhibiting no effect, TENS-L increased the ratio of low/high-frequency power spectrum indicating TENS-R decreased the HR through potentiating cardiac vagal tone. Collectively, these results suggest TENS could be an early and non-invasive therapy for heart failure patients before considering implant devices or devices are not feasible; moreover, therapists/physicians need to carefully monitor the potential adverse events during treatment for patient safety.Trial registration: The study protocol was registered in ClinicalTrials.gov (NCT03982472; 11/06/2019).


Sign in / Sign up

Export Citation Format

Share Document